Your browser doesn't support javascript.
loading
An effective modestly intensive re-induction regimen with bortezomib in relapsed or refractory paediatric acute lymphoblastic leukaemia.
Kaspers, Gertjan J L; Niewerth, Denise; Wilhelm, Bram A J; Scholte-van Houtem, Peggy; Lopez-Yurda, Marta; Berkhof, Johannes; Cloos, Jacqueline; de Haas, Valerie; Mathôt, Ron A; Attarbaschi, Andishe; Baruchel, André; de Bont, Eveline S; Fagioli, Franca; Rössig, Claudia; Klingebiel, Thomas; De Moerloose, Barbara; Nelken, Brigitte; Palumbo, Giuseppe; Reinhardt, Dirk; Rohrlich, Pierre-Simon; Simon, Pauline; von Stackelberg, Arend; Zwaan, Christian Michel.
Afiliação
  • Kaspers GJL; Department of Paediatric Oncology/Haematology, VU University Medical Centre, Amsterdam, the Netherlands.
  • Niewerth D; Princess Máxima Centre for Paediatric Oncology, Utrecht, the Netherlands.
  • Wilhelm BAJ; Department of Paediatric Oncology/Haematology, VU University Medical Centre, Amsterdam, the Netherlands.
  • Scholte-van Houtem P; Clinical Pharmacology and Pharmacy, VU University Medical Centre, Amsterdam, the Netherlands.
  • Lopez-Yurda M; Paediatric Oncology, Erasmus MC, Rotterdam, the Netherlands.
  • Berkhof J; Innovative Therapies for Children with Cancer Consortium, Paris, France.
  • Cloos J; Department of Biometrics, Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • de Haas V; Paediatric Oncology, Erasmus MC - Sophia Children's Hospital, Rotterdam, the Netherlands.
  • Mathôt RA; Department of Epidemiology & Biostatistics, VU University Medical Centre, Amsterdam, the Netherlands.
  • Attarbaschi A; Department of Paediatric Oncology/Haematology, VU University Medical Centre, Amsterdam, the Netherlands.
  • Baruchel A; Dutch Childhood Oncology Group, The Hague, the Netherlands.
  • de Bont ES; Clinical Pharmacology, Academic Medical Centre, University of Amsterdam, Amsterdam, the Netherlands.
  • Fagioli F; Department of Paediatric Haematology and Oncology, St. Anna Children's Hospital, Department of Paediatrics and Adolescent Medicine, Medical University Vienna, Vienna, Austria.
  • Rössig C; Innovative Therapies for Children with Cancer Consortium, Paris, France.
  • Klingebiel T; Dept. of Paediatric Haematology, Hopital Saint Louis, Paris, France.
  • De Moerloose B; Department of Paediatric Oncology/Haematology, Beatrix Children's Hospital, University Medical Centre Groningen, University of Groningen, Groningen, the Netherlands.
  • Nelken B; Università degli Studi di Torino, Turin, Italy.
  • Palumbo G; Paediatric Haematology and Oncology, University Hospital Münster, Münster, Germany.
  • Reinhardt D; Department of Paediatrics, University Hospital Frankfurt, Frankfurt am Main, Germany.
  • Rohrlich PS; Department of Paediatrics, Ghent University Hospital, Ghent, Belgium.
  • Simon P; Paediatric Haematology, Hospital Jeanne de Flandre, Lille, France.
  • von Stackelberg A; Ospedale Pediatrico Bambino Gesù, Rome, Italy.
  • Zwaan CM; Innovative Therapies for Children with Cancer Consortium, Paris, France.
Br J Haematol ; 181(4): 523-527, 2018 05.
Article em En | MEDLINE | ID: mdl-29676440

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Crise Blástica / Leucemia-Linfoma Linfoblástico de Células Precursoras Tipo de estudo: Clinical_trials Limite: Adolescent / Child / Child, preschool / Female / Humans / Male Idioma: En Revista: Br J Haematol Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Holanda

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Crise Blástica / Leucemia-Linfoma Linfoblástico de Células Precursoras Tipo de estudo: Clinical_trials Limite: Adolescent / Child / Child, preschool / Female / Humans / Male Idioma: En Revista: Br J Haematol Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Holanda